Accutane Lawsuits Continue to Mount in New Jersey State Court

|

There are now more than 7,000 Accutane lawsuits pending in New Jersey state court, which allege that the makers of the acne medication failed to adequately warn about the risk of serious and debilitating bowel problems. 

All of the New Jersey state court lawsuits over Accutane and generic versions have been consolidated as a mass tort in Atlantic County before Judge Carol Higbee, and the number of complaints filed in the state has more than doubled over the last year.

The first lawsuit over bowel problems from Accutane was filed in New Jersey in September 2003. While the number of cases pending in the state hit the 3,000 mark early last year, a case list released earlier this month indicates that 7,042 lawsuits are now included as part of the the New Jersey Accutane litigation.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

All of the complaints involve similar allegations that the popular acne drug carried inadequate warnings that side effects of Accutane may increase risk of debilitating inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, which could develop years after the medication is used.

Accutane (isotretinoin) has been used by more than 16 million people worldwide since it was first introduced by Roche in the early 1980s as a treatment for severe acne. The drug maker discontinued Accutane in June 2009, due to the increasing costs associated with the litigation over Accutane, but a number of generic versions remain available under names such as Claravis, Sotret, Amnesteem and generic isotretinoin.

Several Accutane trials have already occurred in New Jersey state court, with a number of multi-million dollar verdicts being returned for damages caused by Accutane.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims.
As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis.
A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit.